The prevalence of mutations in the BAF (BRG1/BRM‐associated factor) chromatin remodeling complexes may represent an opportunity to help close this gap: These critical regulators of chromatin accessibility are mutated in approximately a quarter of NSCLC cases, and numerous retrospective reports have evaluated the impact of these mutations on clinical outcomes. The gene discussed is SMARCA4; the disease is non-small cell lung carcinoma.